Powell, Reid
individual record
Research Assistant Professor
Positions:
- Research Assistant Professor, Institute of Biosciences and Technology, School of Medicine
selected publications
Academic Articles42
- Shah, P. A., Mazumdar, T., Powell, R. T., Shen, L. i., Wang, J., Stephen, C. C., Frederick, M. J., & Johnson, F. M. (2023). Abstract 2847: Concurrent inactivation of PI3K and PLK1 is synergistic and overcomes acquired resistance to PI3K inhibitors in NOTCH1 MUT HNSCC. Cancer Research. 83(7_Supplement), 2847-2847.
- Welte, T., Vuttaradhi, V., Khlebus, E., Lawson, B., Hillman, R. T., Nguyen, N., ... Stephan, C. (2023). Abstract 453: Targeting FOXL2C402G vulnerabilities in adult type ovarian granulosa cell tumors. Cancer Research. 83(7_Supplement), 453-453.
- Ghosh, S., Fan, F., Roszik, J., Powell, R., Park, Y., Stephan, C., Ellis, L. M., & Bhattacharya, R. (2023). Abstract 4994: Crizotinib enhances the efficacy of BX-795 identified by high-throughput screening of pan-active drugs in colorectal cancer cells. Cancer Research. 83(7_Supplement), 4994-4994.
- Yu, W., Chen, Y., Putluri, N., Osman, A., Coarfa, C., Putluri, V., ... Sandulache, V. C. (2023). Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.. Br J Cancer. 1-12.
- Abdulkareem, N., Bhat, R., Powell, R., Chikermane, S., Yande, S., Trinh, L., ... Trivedi, M. (2023). Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer. Cancer Research. 83(5_Supplement), p6-10-19-p6-10-19.
Chapters1
- Lehrer, M., Powell, R. T., Barua, S., Kim, D., Narang, S., & Rao, A. (2017). Radiogenomics and Histomics in Glioblastoma: The Promise of Linking Image-Derived Phenotype with Genomic Information. ADVANCES IN BIOLOGY AND TREATMENT OF GLIOBLASTOMA. 143-159. Springer Nature.
Conference Papers10
- Braun, F. K., Brabetz, S., Qi, L., Du, Y., Kogiso, M., Zhang, H. Y., ... Li, X. (2022). MOLECULAR LANDSCAPE OF A COMPREHENSIVE PANEL OF PEDIATRIC BRAIN CANCER PATIENT-DERIVED ORTHOTOPIC XENOGRAFT (PDOX) MODELS INFORM UNIQUE TARGETS FOR DRUG RESPONSIVENESS. NEURO-ONCOLOGY. 24, 175-175.
- Ghosh, S., Fan, F., Roszik, J., Powell, R., Park, Y., Stephan, C., Ellis, L. M., & Bhattacharya, R. (2022). Determining efficacy of combining the MEK inhibitor trametinib with vincristine identified by unbiased high throughput screening in RAS-mutated colorectal cancer cells. CANCER RESEARCH. 82(12),
- Ghosh, S., Mazumdar, T., Xu, W., Powell, R. T., Stephan, C., Shen, L. i., ... Johnson, F. M. (2022). Rb deficient HPV plus HNSCC experienced enhanced sensitivity to aurora kinase inhibitors by altering the balance of MAD2 and TRIP13 levels. CANCER RESEARCH. 82(12),
- Mazumdar, T., Shen, L. i., Xu, W., Ghosh, S., Powell, R. T., Stephan, C., ... Johnson, F. M. (2021). Aurora kinase inhibitors cause cell death in HPV plus cells: A plausible treatment option for HPV plus cancers.. CANCER RESEARCH. 81(13),
- Shah, P. A., Mazumdar, T., Powell, R. T., Shen, L. i., Wang, J., Stephen, C. C., Frederick, M. J., & Johnson, F. M. (2021). Identification of pathways that enhance cell death in NOTCH1-mutant HNSCC.. CANCER RESEARCH. 81(13),
Repository Documents / Preprints3
- Marreddy, R., Picker, J., Phelps, G. A., Powell, R., Cherian, P. T., Bowling, J. J., ... Hurdle, J. G. (2022). The licorice metabolite enoxolone attenuates Clostridioides difficile pathophysiology by corrupting its metabolic and toxin production networks.
- Tahaney, W. M., Qian, J., Moyer, C. L., Nguyen, N., Lanier, A., Ma, Y., ... Brown, P. H. (2022). Inhibition of GPX4 Induces the Death of p53-Mutant Triple-Negative Breast Cancer.
- Xia, J., Chiu, L., Nehring, R. B., Nez, M., Mei, Q., Perez, M., ... Rosenberg, S. M. (2018). Bacteria-to-human protein networks reveal origins of endogenous DNA damage.
Email
repowell@tamu.edu
First Name
Reid
Last Name
Powell